Aktien Sensor

Jiangsu Hengrui Pharmaceuticals has received approval from China’s securities regulator for its Hong Kong listing, bringing the company one step closer to a potential share sale that could raise substantial funds.

Jiangsu Hengrui Pharmaceuticals Co., Ltd. has obtained a drug registration certificate, a key milestone announced on January 12.